logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11331343 B1

PDFFull Text
Date of Patent:
May. 17, 2022

Filed:

Jun. 29, 2017

Compositions and methods for activating antigen presenting cells with chimeric poliovirus

Applicant:

Duke University, Durham, NC (US);

Inventors:

Smita Nair, Durham, NC (US);

Michael Brown, Durham, NC (US);

Darell Bigner, Mebane, NC (US);

Matthias Gromeier, Durham, NC (US);

Assignee:

Duke University, Durham, NC (US);

Attorney:

Banner & Witcoff, Ltd.

Primary Examiner:

Nicole Kinsey White

Int. Cl.
CPC ...
A61P 1/00 (2006.01); A61P 35/00 (2006.01); A61K 31/7105 (2006.01); A61K 35/76 (2015.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 45/06 (2006.01); A61K 35/15 (2015.01); A61K 9/00 (2006.01); A61K 35/14 (2015.01); C12N 5/0784 (2010.01); A61P 31/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/15 (2013.01); A61K 9/007 (2013.01); A61K 9/0043 (2013.01); A61K 9/0053 (2013.01); A61K 31/7105 (2013.01); A61K 35/14 (2013.01); A61K 35/76 (2013.01); A61K 39/0011 (2013.01); A61K 39/39 (2013.01); A61K 45/06 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C12N 5/0639 (2013.01); A61K 2039/55561 (2013.01); Y02A 50/30 (2018.01);
Abstract

Chimeric poliovirus is capable of activating antigen presenting cells. The activation of the antigen presenting cells may be in vitro, ex vivo, or in vivo. The activated antigen presenting cells may be administered alone or with an antigen or vaccine. The activated antigen may be loaded in vitro or ex vivo with antigen to form antigen-loaded, activated, antigen presenting cells. These may be administered therapeutically. Therapeutic administration of antigen presenting cells may be used as an adjuvant to other therapies.

Find Patent Forward Citations

Nair, Smita. (2022). Compositions and methods for activating antigen presenting cells with chimeric poliovirus (U.S. Patent No. 11331343). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11331343

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…